Ashford Capital Management’s uniQure QURE Stock Holding History

Ashford Capital Management’s Portfolio QURE Stock Details QURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,000	Closed	-$239K	–	111
2025 Q4	$239K	Buy	+10,000	New	+$386K	0.03%	101

Other funds holding QURE

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Ashford Capital Management's QURE Position: Q1 2026 in Review

Ashford Capital Management sold out of uniQure (QURE) in Q1 2026, closing a stake of 10,000 shares — an estimated $239K sold.

Ashford Capital Management first reported a position in QURE in Q4 2025 and held it in 1 quarter. The position peaked at $239K in Q4 2025. 214 funds tracked by Wall St. Rank hold QURE as of Q1 2026.

Ashford Capital Management reported no remaining uniQure position as of Q1 2026 after selling out during the quarter.
Ashford Capital Management sold 10,000 uniQure shares in Q1 2026, an estimated $239K.
Ashford Capital Management first reported a position in uniQure in Q4 2025 and held it in 1 quarter.
Ashford Capital Management's uniQure position peaked at $239K in Q4 2025.
214 funds tracked by Wall St. Rank held uniQure as of Q1 2026.

Based on Ashford Capital Management's 13F filing for Q1 2026, filed 15 May 2026.